@article{d07a04d68762470e9c642bd8b931b3a6,
title = "Long- Versus Short-Acting Erythropoiesis-Stimulating Agent Type and Mortality",
author = "Angelo Karaboyas and Port, \{Friedrich K.\} and Massy, \{Ziad A.\} and Francesco Locatelli and Aleix Cases and Kosaku Nitta and Sophie Liabeuf and Jager, \{Kitty J.\} and Robinson, \{Bruce M.\}",
note = "Funding Information: AK and BR are employees of Arbor Research Collaborative for Health, and FKP has a consultancy contract with Arbor Research Collaborative for Health, which administers the DOPPS. BR has received consultancy fees or travel reimbursement from AstraZeneca, GlaxoSmithKline, and Kyowa Kirin Co., all paid directly to his institution of employment. ZAM reports grants for CKD REIN and other research projects from Amgen, Astra Zeneca, Baxter, Fresenius Medical Care, GlaxoSmithKline, Merck Sharp and Dohme-Chibret, Sanofi-Genzyme, Lilly, Otsuka and the French government, as well as fees and grants to charities from Astellas, and Sanofi-Genzyme. FL is or was a member of an advisory board of Akebia, Amgen, Astellas, Astra Zeneca, Baxter, GSK, Mitsubishi, Roche, and Vifor Pharma, and has been a speaker at meetings supported by Amgen, Astellas, Bayer, Norgine, Roche, and Vifor Pharma. AC has received grants from Vifor Pharma and AB-Biotics, is or was a member of an advisory board of Astellas, GlaxoSmithKline, Vifor Pharma, Daiichi Sankyo, and Novo Nordisk, and has received speaker fees from Astellas, Amgen, Bayer, and Vifor Pharma. KN has received research grants from Chugai Pharmaceutical Co. and Kyowa Kirin Co. Ltd. KJJ has received speaker fees from Fresenius Medical Care. SL declared no competing interests.",
year = "2021",
month = jan,
doi = "10.1016/j.ekir.2020.10.003",
language = "English",
volume = "6",
pages = "214--218",
journal = "Kidney International Reports",
issn = "2468-0249",
publisher = "Elsevier Inc.",
number = "1",
}